Haemonetics (HAE) Treasury Shares (2011 - 2026)

Haemonetics' Treasury Shares history runs 16 years deep, the most recent figure standing at $357631.0 for Q1 2026.

• On a quarterly basis, Treasury Shares rose 6.49% year-over-year to $357631.0 in Q1 2026; TTM through Mar 2026 was $357631.0, a 6.49% increase from a year earlier, with the FY2026 full-year figure at $357631.0, up 6.49% from the prior year.
• Treasury Shares improved to $357631.0 in Q1 2026 per HAE's latest filing, from $332292.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $381531.0 in Q2 2025 and bottomed at $282946.0 in Q2 2022.
• The 5-year median for Treasury Shares is $356025.0 (2025), against an average of $349471.2.
• Across the five-year window, Treasury Shares soared 34.76% in 2023 and fell 9.18% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $282946.0 in 2022, then soared by 34.76% to $381308.0 in 2023, then slipped by 3.02% to $369800.0 in 2024, then slipped by 10.14% to $332292.0 in 2025, then rose by 7.63% to $357631.0 in 2026.
• Per Business Quant, the three latest HAE Treasury Shares figures stand at $357631.0 (Q1 2026), $332292.0 (Q4 2025), and $354419.0 (Q3 2025).